could glp-1 be the next mental health drug Can Drugs Improve Beyond Weight Loss? Have you been prescribed GLP-1
Description
In clinical studies with adults with type 2 diabetes, Bydureon BCise lowered A1C by an average of 1.1 to 1.4% from an average starting A1C of 8.4 to 8.5%
The 6-minute walk test from baseline improved over 20 meters in the treatment group but only 1 meter in the placebo group
And so these were originally type 2 diabetes treatments, and now they have since moved on to become weight-loss treatments
This medication is a glucagon-like peptide-1 (GLP-1) receptor agonist prescribed for type 2 diabetes management
L., John, L
In the case of hepatic steatosis, insulin signaling pathways are largely deficient
